Muncie, IN, United States of America

Mohammad Behforouz


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1996-2005

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Mohammad Behforouz

Introduction

Mohammad Behforouz is a prominent inventor based in Muncie, Indiana, recognized for his significant contributions to the field of chemistry and medicinal compounds. With an impressive portfolio of six patents, Behforouz has established himself as a key figure in the development of novel medical therapeutics.

Latest Patents

Among his notable inventions, Behforouz has developed innovative lavendamycin analogs and quinoline-5,8-diones. These compounds are represented by specific general formulas that highlight their unique structural properties. The patents detail methods of making and using these compounds, offering new avenues for therapeutic applications and compositions that incorporate these novel chemical entities.

Career Highlights

Throughout his career, Mohammad Behforouz has worked at various esteemed institutions, including Ball State University. His research and innovation have received recognition for their potential impact on medical science and pharmaceutical development.

Collaborations

Behforouz has collaborated with several professionals in his field, including coworkers Nancy C. Behforouz and Ronald Lynn Merriman. These partnerships have enriched his research endeavors, fostering a collaborative environment that supports the advancement of innovative solutions.

Conclusion

With a strong background in research and several patents to his name, Mohammad Behforouz continues to contribute to the evolution of medicinal chemistry. His innovative work exemplifies the dedication to advancing scientific knowledge and developing new therapeutic options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…